Shandong Weigao Medical Polymer Co. (OTCMKTS:SHWGF) Sees Large Increase in Short Interest

Key Points

• Short interest surged to 4,451,429 shares as of April 15, a 745.8% increase from March 31, producing an unusually high short-interest ratio of 816.0 days based on average daily volume.
• Shares are trading flat at $0.45 with a 50-day moving average of $0.63, a 200-day moving average of $0.67, and a 12-month range of $0.45–$0.73.
• Shandong Weigao is a Weihai, Shandong–based manufacturer of single-use medical devices and medical polymer products, including infusion sets, disposable syringes, catheters, blood filters and apheresis sets.

Shandong Weigao Medical Polymer Co. (OTCMKTS:SHWGF - Get Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totaling 4,451,429 shares, a growth of 745.8% from the March 31st total of 526,267 shares. Based on an average trading volume of 5,455 shares, the short-interest ratio is currently 816.0 days. Currently, 0.1% of the company's shares are sold short.

Shandong Weigao Medical Polymer Stock Performance

Shares of Shandong Weigao Medical Polymer stock remained flat at $0.45 on Friday. The firm has a 50-day moving average of $0.63 and a 200 day moving average of $0.67. Shandong Weigao Medical Polymer has a 12 month low of $0.45 and a 12 month high of $0.73.

Shandong Weigao Medical Polymer Company Profile

Shandong Weigao Medical Polymer Co, Ltd. OTCMKTS: SHWGF is a China-based manufacturer of single-use medical devices and medical polymer products. Headquartered in Weihai, Shandong Province, the company operates under the umbrella of the Weigao Group and focuses on the development, production and distribution of disposable medical consumables.

The company's product portfolio encompasses infusion and transfusion sets, disposable syringes, intravenous catheters, blood filters and apheresis sets, as well as devices for enteral nutrition and medical-grade tubing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.